HK1048137A1 - 來自基質細胞的多核苷酸序列和推斷的氨基酸序列 - Google Patents

來自基質細胞的多核苷酸序列和推斷的氨基酸序列 Download PDF

Info

Publication number
HK1048137A1
HK1048137A1 HK03100235.2A HK03100235A HK1048137A1 HK 1048137 A1 HK1048137 A1 HK 1048137A1 HK 03100235 A HK03100235 A HK 03100235A HK 1048137 A1 HK1048137 A1 HK 1048137A1
Authority
HK
Hong Kong
Prior art keywords
leu
gly
ser
val
ala
Prior art date
Application number
HK03100235.2A
Other languages
English (en)
Chinese (zh)
Inventor
Strachan Lorna
Sleeman Matthew
Abernethy Nevin
Onrust Rene
D. Kumble Krishanand
Greg Murison James
Original Assignee
吉尼西斯研究及发展有限公司
吉尼西斯研究及發展有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 吉尼西斯研究及发展有限公司, 吉尼西斯研究及發展有限公司 filed Critical 吉尼西斯研究及发展有限公司
Publication of HK1048137A1 publication Critical patent/HK1048137A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03100235.2A 1999-03-25 2000-02-18 來自基質細胞的多核苷酸序列和推斷的氨基酸序列 HK1048137A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27626899A 1999-03-25 1999-03-25
US09/383,586 US6242419B1 (en) 1999-03-25 1999-08-26 Compositions isolated from stromal cells and methods for their use
US09/383,586 1999-08-26
PCT/NZ2000/000015 WO2000058463A1 (en) 1999-03-25 2000-02-18 Polynucleotide and deduced amino acid sequences from stromal cells

Publications (1)

Publication Number Publication Date
HK1048137A1 true HK1048137A1 (zh) 2003-03-21

Family

ID=26957887

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03100235.2A HK1048137A1 (zh) 1999-03-25 2000-02-18 來自基質細胞的多核苷酸序列和推斷的氨基酸序列

Country Status (9)

Country Link
US (1) US6242419B1 (https=)
EP (1) EP1163334A4 (https=)
JP (1) JP2002539827A (https=)
CN (1) CN1358228A (https=)
AU (1) AU782974B2 (https=)
CA (1) CA2368477A1 (https=)
HK (1) HK1048137A1 (https=)
NZ (1) NZ514329A (https=)
WO (1) WO2000058463A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074897B2 (en) * 1997-06-16 2006-07-11 Genentech, Inc. Pro943 polypeptides
US20030143676A1 (en) * 1999-03-25 2003-07-31 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US6743907B1 (en) * 1999-10-19 2004-06-01 Lexicon Genetics Incorporated Human proteins and polynucleotides encoding the same
EP1240198A4 (en) * 1999-10-19 2003-11-05 Millennium Pharm Inc GENES ENCODING PROTEINS WITH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER APPLICATIONS
US7348162B2 (en) * 2000-03-22 2008-03-25 Amgen Inc. Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof
US6812002B2 (en) * 2000-08-30 2004-11-02 Pfizer Inc. Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
JP2002272470A (ja) * 2001-03-21 2002-09-24 Takashi Nakamura リジルオキシダーゼ関連タンパク質をコードする核酸
EP1508340A4 (en) 2002-05-24 2009-07-01 Takeda Pharmaceutical MEANS FOR IMPROVING INSULIN RESISTANCE
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1597577A4 (en) * 2003-02-10 2007-02-21 Pointilliste Inc SELF-ARRANGING ARRAYS AND ITS APPLICATION
WO2005040205A1 (en) * 2003-10-28 2005-05-06 Protemix Discovery Limited Peptides with anti-obesity activity and other related uses
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
US20090297479A1 (en) * 2008-03-28 2009-12-03 Kiyoshi Ariizumi Dc-hil conjugates for treatment of t-cell disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009327A2 (en) * 1999-07-28 2001-02-08 Genentech, Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
CA2328895A1 (en) 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000024756A1 (en) 1998-10-23 2000-05-04 Human Genome Sciences, Inc. Fibroblast growth factor receptor-5
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2495200A (en) * 1999-03-08 2000-09-28 Genentech Inc. Compositions and methods for the treatment of tumor
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
AU5907800A (en) * 1999-06-30 2001-01-31 Millennium Pharmaceuticals, Inc. Membrane-associated and secreted proteins and uses thereof
WO2001053312A1 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001238488A1 (en) * 2000-02-17 2001-08-27 Incyte Genomics, Inc. Human kinases

Also Published As

Publication number Publication date
US6242419B1 (en) 2001-06-05
NZ514329A (en) 2003-07-25
AU2702100A (en) 2000-10-16
CA2368477A1 (en) 2000-10-05
JP2002539827A (ja) 2002-11-26
EP1163334A4 (en) 2004-07-28
EP1163334A1 (en) 2001-12-19
AU782974B2 (en) 2005-09-15
CN1358228A (zh) 2002-07-10
WO2000058463A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
CN1107072C (zh) 编程性细胞死亡诱导分子ⅱ
CN1105187C (zh) 原钙粘着蛋白蛋白质及其应用
CN1267550C (zh) 血管内皮生长因子2
HK1048137A1 (zh) 來自基質細胞的多核苷酸序列和推斷的氨基酸序列
CN1446227A (zh) 新型成纤维细胞生长因子(fgf23)及其使用方法
CN1232469A (zh) 刺激神经和肾生长的RET配体(RetL)
CN1552855A (zh) 人血管内皮生长因子2
CN1367829A (zh) 用于肺癌治疗和诊断的组合物和方法
CN1474869A (zh) 新型化合物
CN1175956A (zh) 新型蛋白质及其制备方法
CN1308451C (zh) 肿瘤坏死因子相关配基
CN1275162A (zh) 包含死亡结构域的受体－5
CN1282372A (zh) 哺乳动物细胞因子样多肽－10
CN1409757A (zh) 用于修饰基因转录的组合物和方法
CN1352680A (zh) 分离自植物细胞的组合物以及它们在植物细胞信号修饰中的应用
CN1464057A (zh) 具有骨骼肌刺激活性和免疫调节作用的趋化素样因子超家族
CN1399644A (zh) 新的人g蛋白偶联受体
CN1414020A (zh) 成纤维细胞生长因子11的抗体、拮抗剂及激动剂
CN1240836C (zh) 转化生长因子αHI
CN1169954C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1371421A (zh) 坦科聚合酶2材料和方法
CN1209373C (zh) 具有抑制癌细胞生长功能的新的人蛋白及其编码序列
CN1169956C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸
CN1193041C (zh) 具有抑制癌细胞生长功能的人蛋白及其编码序列
CN1169955C (zh) 编码具有抑制癌细胞生长功能的人蛋白的多核苷酸